Denali Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 14, 2020 / 03:15PM GMT
Matthew Kelsey Harrison - Morgan Stanley, Research Division - Executive Director

Everybody, good morning, and thanks for joining us for the next session. I'm Matthew Harrison, one of the biotech analysts here at Morgan Stanley. So I just need a quick disclaimer I need to read.

Please note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only. This webcast is not for members of the press. If you are a member of the press, please disconnect and reach out separately. For important disclosures, please see the Morgan Stanley disclosures website at morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales representative.

So very pleased to have Ryan Watts, the CEO of Denali with me. Ryan, I'm going to turn it over to you to make an opening comment or 2, and then we'll get into Q&A.

Ryan J. Watts - Denali Therapeutics Inc. - Co-Founder, President, CEO & Director

Matthew, great to be with you. I, of course, would love to be with you on stage in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot